These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20490776)

  • 1. Dendritic cell subsets as vectors and targets for improved cancer therapy.
    Palucka K; Ueno H; Roberts L; Fay J; Banchereau J
    Curr Top Microbiol Immunol; 2011; 344():173-92. PubMed ID: 20490776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells: are they clinically relevant?
    Palucka K; Ueno H; Roberts L; Fay J; Banchereau J
    Cancer J; 2010; 16(4):318-24. PubMed ID: 20693842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells and immunity against cancer.
    Palucka K; Ueno H; Fay J; Banchereau J
    J Intern Med; 2011 Jan; 269(1):64-73. PubMed ID: 21158979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells and cancer immunotherapy.
    Radford KJ; Tullett KM; Lahoud MH
    Curr Opin Immunol; 2014 Apr; 27():26-32. PubMed ID: 24513968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
    Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies.
    Galati D; Zanotta S
    Cytotherapy; 2018 Nov; 20(11):1309-1323. PubMed ID: 30360963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic Cell-Based Cancer Vaccines.
    Santos PM; Butterfield LH
    J Immunol; 2018 Jan; 200(2):443-449. PubMed ID: 29311386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell based tumor vaccines.
    Nouri-Shirazi M; Banchereau J; Fay J; Palucka K
    Immunol Lett; 2000 Sep; 74(1):5-10. PubMed ID: 10996622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building on dendritic cell subsets to improve cancer vaccines.
    Palucka K; Ueno H; Zurawski G; Fay J; Banchereau J
    Curr Opin Immunol; 2010 Apr; 22(2):258-63. PubMed ID: 20226644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells: a critical player in cancer therapy?
    Palucka AK; Ueno H; Fay J; Banchereau J
    J Immunother; 2008; 31(9):793-805. PubMed ID: 18833008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting dendritic cells in the development of cancer vaccines.
    Bracci L; Capone I; Moschella F; Proietti E; Belardelli F
    Expert Rev Vaccines; 2013 Oct; 12(10):1195-210. PubMed ID: 24090117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells.
    Ramachandran M; Dimberg A; Essand M
    Semin Cancer Biol; 2017 Aug; 45():23-35. PubMed ID: 28257957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents.
    Truxova I; Hensler M; Skapa P; Halaska MJ; Laco J; Ryska A; Spisek R; Fucikova J
    Int Rev Cell Mol Biol; 2017; 330():115-156. PubMed ID: 28215530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours.
    Huang FP; Chen YX; To CK
    Eur J Immunol; 2011 Jan; 41(1):18-25. PubMed ID: 21182072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells.
    Bol KF; Schreibelt G; Rabold K; Wculek SK; Schwarze JK; Dzionek A; Teijeira A; Kandalaft LE; Romero P; Coukos G; Neyns B; Sancho D; Melero I; de Vries IJM
    J Immunother Cancer; 2019 Apr; 7(1):109. PubMed ID: 30999964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-based immunotherapy: a basic review and recent advances.
    Constantino J; Gomes C; Falcão A; Neves BM; Cruz MT
    Immunol Res; 2017 Aug; 65(4):798-810. PubMed ID: 28660480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic Cells and Cancer Immunity.
    Gardner A; Ruffell B
    Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.